1. Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma
    Zheng-Yue Dou et al, 2023, Hematology CrossRef
  2. NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
    Barry E. Kennedy et al, 2022, Molecular Therapy - Oncolytics CrossRef
  3. Diabetes mellitus and multiple myeloma; common features of two distinct entities
    Anastasios Tentolouris et al, 2022, Diabetes/Metabolism Research and Reviews CrossRef
  4. PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors
    Chi Luo et al, 2016, Trends in Cancer CrossRef
  5. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells
    Huiling Mei et al, 2018, International Journal of Molecular Medicine CrossRef
  6. Novel insights into redox system and the mechanism of redox regulation
    Xin Wang et al, 2016, Molecular Biology Reports CrossRef
  7. Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
    Timon A. Bloedjes et al, 2021, Cancers CrossRef
  8. Redox modulation of adipocyte differentiation: hypothesis of “Redox Chain” and novel insights into intervention of adipogenesis and obesity
    Xin Wang et al, 2015, Free Radical Biology and Medicine CrossRef
  9. SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation
    Yu Xiang et al, 2020, Life Sciences CrossRef
  10. Impact of hyperglycemia on the efficacy of chemotherapy—A systematic review of preclinical studies
    Maaike C. Gerards et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
  11. Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma
    Irit Avivi et al, 2021, Leukemia & Lymphoma CrossRef